phosphatidylcholines has been researched along with tazobactam in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 1,327 | 153 | 694 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | tazobactam (IC50) |
|---|---|---|---|
| Beta-lactamase | Klebsiella pneumoniae | 0.08 | |
| Beta-lactamase | Escherichia coli | 0.01 | |
| Beta-lactamase | Citrobacter freundii | 0.096 | |
| Beta-lactamase | Citrobacter gillenii | 0.04 | |
| Beta-lactamase | Shouchella clausii | 0.004 | |
| Beta-lactamase | Burkholderia cenocepacia | 0.5 | |
| Beta-lactamase | Pseudomonas aeruginosa | 0.06 | |
| Beta-lactamase | Pseudomonas aeruginosa | 2 | |
| B2 bradykinin receptor | Cavia porcellus (domestic guinea pig) | 4.8 | |
| Beta-lactamase | Staphylococcus aureus | 0.5 | |
| Beta-lactamase | Bacillus licheniformis | 0.51 | |
| Beta-lactamase | Escherichia coli K-12 | 0.25 | |
| Beta-lactamase | Citrobacter freundii | 0.93 | |
| Beta-lactamase | Enterobacter cloacae | 1.3748 | |
| Beta-lactamase SHV-1 | Escherichia coli | 0.222 | |
| Beta-lactamase SHV-1 | Klebsiella pneumoniae | 0.11 | |
| Beta-lactamase OXA-1 | Escherichia coli | 4.8 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.83 | |
| Cytochrome P450 2B6 | Homo sapiens (human) | 0.11 | |
| Beta-lactamase | Pseudomonas aeruginosa PAO1 | 2.51 | |
| Beta-lactamase TEM | Escherichia coli | 0.0828 | |
| Beta-lactamase | Morganella morganii | 0.19 | |
| Beta-lactamase | Salmonella enterica subsp. enterica serovar Westhampton | 0.0022 | |
| Beta-lactamase | Pseudomonas aeruginosa | 2 | |
| Beta-lactamase | Enterobacter cloacae | 0.03 | |
| Class D beta-lactamase | Brachyspira pilosicoli | 0.16 | |
| Beta-lactamase | Pseudomonas luteola | 0.04 | |
| Beta-lactamase | Escherichia coli | 0.24 | |
| Beta-lactamase | Serratia fonticola | 6.9 | |
| Beta-lactamase | Enterobacter cloacae | 0.06 | |
| Beta-lactamase | Escherichia coli | 0.002 | |
| Carbapenem-hydrolyzing beta-lactamase KPC | Klebsiella pneumoniae | 0.372 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, AS; Lau, W | 1 |
1 other study(ies) available for phosphatidylcholines and tazobactam
| Article | Year |
|---|---|
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |